Amgen's drug portfolio boasts several biologic drugs that are blockbuster sellers. In acquiring ChemoCentryx for $3.7 billion, the pharmaceutical giant gains a company entirely focused on developing small molecule alternatives to biologic medicines.
Currently, according to Tufts researchers, clinical trials in a variety of therapeutic areas experience patient dropout rates close to 20%, with the consent process being the number 1 factor contributing to this figure.
It is critical that the consent process be tailored to ensure that participants understand what's being asked of them and how their data will help further future disease treatment. The Solution: eConsent
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. This is your chance to save $100 with the Early Bird Rate (Ends 8/26).
Complementary and integrative healthcare providers, including chiropractic physicians, acupuncturists, and massage therapists, provide effective and safe treatments for pain. Yet, they are too often overlooked by Congress and a healthcare system that tends to default to pharmacological treatments as the first step in pain reduction.
Helping your employees quit vaping increases workplace productivity and reduces the overall impact on your business's bottom line. The sooner you implement an effective vaping cessation program, the better it will be for your employees and organization.
By applying a more comprehensive maternity journey, we are able to address social determinants of health that vary by population, geography, and community – and are estimated to impact 80% of an individual's overall, long-term health.
Homeward is working to fill in the gap of primary and specialty care in rural areas. Currently working in Michigan, it hopes to use the funding to expand into other markets.
Enhertu, a breast cancer drug from AstraZeneca and Daiichi Sankyo, is now FDA approved for treating patients whose tumors express low levels of the protein HER2. The decision makes the infused therapy the first targeted treatment for this new category of breast cancer patients.
Medications that treat opioid use disorder (OUD) — such as methadone, buprenorphine and extended-release naltrexone — are proven to save lives. However, a new study revealed that less than 15% of Americans with OUD receive these medications. Its lead author laid out three actions the U.S. should prioritize to increase access.
By April Zambelli-Weiner Friday, August 5, 2022 10:00 AM
For most companies and medtech, in particular, good business practices (GBP) happens on multiple levels. On the micro level, it's more prescriptive (i.e., regulatory best practices or good manufacturing practices). On the macro level, it's expressed as a set of ethics and principles that govern a company's conduct.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments